Segment Results (Additional Selected Financial Information For Reportable Segments) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Segment Reporting Information [Line Items]
Depreciation expense:	$ 17,723	$ 13,447
Amortization expense:	49,096	53,510
Endo Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Depreciation expense:	6,305	3,798
Amortization expense:	21,280	21,934
Qualitest [Member]
Segment Reporting Information [Line Items]
Depreciation expense:	3,170	2,937
Amortization expense:	10,881	10,381
AMS [Member]
Segment Reporting Information [Line Items]
Depreciation expense:	2,802	2,656
Amortization expense:	15,239	19,406
HealthTronics [Member]
Segment Reporting Information [Line Items]
Depreciation expense:	2,981	2,992
Amortization expense:	1,696	1,789
Corporate Unallocated [Member]
Segment Reporting Information [Line Items]
Depreciation expense:	$ 2,465	$ 1,064